mabxience.comLeading international biopharmaceutical

mabxience.com Profile

mabxience.com is a domain that was created on 2010-02-17,making it 14 years ago. It has several subdomains, such as cdmo.mabxience.com , among others.

Description：mAbxience is a global, vertically integrated fully-fledged biotechnology company, with over a decade of experience in the development, manufacture and commercialization of...

Discover mabxience.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site

mabxience.com Information

HomePage size: 155.801 KB
Page Load Time: 0.892772 Seconds
Website IP Address: 45.60.243.89

mabxience.com Similar Website

Center for Biopharmaceutical Education & Training - CBET cbet.acphs.edu
ASTRA Altrusa International astra.altrusa.org
Business Ethics for APEC SMEs - Biopharmaceutical Sector mcprinciples.apec.org
Hotel Baglioni Regina - The Leading Hotels of the World, Rome. Baglioni Regina - The Leading Hotels reginabaglioni.hotelinroma.com
Research & Biopharmaceutical Manufacturing - Cytiva (formerly GE Healthcare Life Sciences) bioprocess.gelifesciences.com
Careers \| Pfizer: One of the world's premier biopharmaceutical companies graduateprogramme.pfizercareersuk.com
Innovative Biopharmaceutical Solutions \| Saint-Gobain biopharm.saint-gobain.com
Global Biopharmaceutical Company - Bristol Myers Squibb coumadin.bmscustomerconnect.com
Pfizer One of the worlds premier biopharmaceutical companies press.pfizer.com
Parexel Biopharmaceutical Services & Clinical Research sis.parexel.com
Leading international biopharmaceutical cdmo.mabxience.com

mabxience.com DNS

A mabxience.com. 3463 IN A 45.60.243.89
MX mabxience.com. 3600 IN MX 10 mxa-006e4c02.gslb.pphosted.com.
NS mabxience.com. 3600 IN NS dns1.chemogroup.net.
TXT mabxience.com. 3600 IN TXT MS=ms63520918
SOA mabxience.com. 3600 IN SOA dns1.chemogroup.net. dnsadmin.chemogroup.net. 270 900 600 86400 3600

mabxience.com Httpheader

Server: nginx
Date: Thu, 16 May 2024 19:28:42 GMT
Content-Type: text/html; charset=UTF-8
Connection: keep-alive
X-Frame-Options: sameorigin
Link: https://mabxience.com/wp-json/; rel="https://api.w.org/", https://mabxience.com/wp-json/wp/v2/pages/4; rel="alternate"; type="application/json", https://mabxience.com/; rel=shortlink
Set-Cookie: pll_language=en; expires=Fri, 16 May 2025 19:28:42 GMT; Max-Age=31536000; path=/; secure; SameSite=Lax, incap_ses_1248_3030279=dwfVfgERrCFzlR9EcclREWpeRmYAAAAA+JWzh9Mw5/9SfS7rvh+lBQ==; path=/; Domain=.mabxience.com
Accept-Ranges: none
Vary: Accept-Encoding
X-Powered-By: Loading
X-CDN: Imperva
Transfer-Encoding: chunked
X-Iinfo: 12-26538440-26538452 NNNN CT(178 169 0) RT(1715887720918 60) q(0 0 4 1) r(5 14)

mabxience.com Meta Info

content="IE=edge" http-equiv="X-UA-Compatible"/
content="text/html; charset=utf-8" http-equiv="Content-Type"/
content="width=device-width, initial-scale=1" name="viewport"/
content="index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1" name="robots"/
content="mAbxience is a global, vertically integrated fully-fledged biotechnology company, with over a decade of experience in the development, manufacture and commercialization of biopharmaceutical medicines." name="description"/
content="en_US" property="og:locale"/
content="es_ES" property="og:locale:alternate"/
content="website" property="og:type"/
content="Leading international biopharmaceutical company" property="og:title"/
content="mAbxience is a global, vertically integrated fully-fledged biotechnology company, with over a decade of experience in the development, manufacture and commercialization of biopharmaceutical medicines." property="og:description"/
content="https://mabxience.com/"

mabxience.com Ip Information

Ip Country: United States
Latitude: 37.751
Longitude: -97.822

mabxience.com Html To Plain Text

company English Español Toggle NavigationThe company Facilities Values Leadership team Biopharmaceutical development Pipeline R&D Partnerships CDMO services Capabilities Products Case studies Media center Press releases Blog Videos Contact Get in touch Find our sites Join us Toggle NavigationThe company Facilities Values Leadership team Biopharmaceutical development Pipeline R&D Partnerships CDMO services Capabilities Products Case studies Media center Press releases Blog Videos Contact Get in touch Find our sites Join usThe company Facilities Values Leadership team Biopharmaceutical development Pipeline R&D Partnerships CDMO services Capabilities Products Case studies Media center Press releases Blog Videos Contact Get in touch Find our sites Join us mAbxience adminchemo 2024-05-13T17:30:25+02:00 Sorry,in the development and commercialization of biopharmaceuticals. READ MORE JOIN US! Do you want to work at mAbxience? Job openings WHAT’S NEW? Catch up with our latest developments Miguel Martínez-Cava 2024-05-09T09:42:26+02:00 May 9, 2024 | mAbxience Appoints Jurgen Van Broeck as New CEO Miguel Martínez-Cava 2024-05-09T09:42:26+02:00 Read More Miguel Martínez-Cava 2024-05-09T09:42:26+02:00 May 9, 2024 | mAbxience Appoints Jurgen Van Broeck as New CEO Miguel Martínez-Cava 2024-05-09T09:42:26+02:00 Press releases | Miguel Martínez-Cava 2024-04-04T14:38:15+02:00 Read More Miguel Martínez-Cava 2024-04-04T14:38:15+02:00 April 4, 2024 | mAbxience and Teva Announce Strategic Global Licensing Agreement for Oncology Biosimilar Candidate Miguel Martínez-Cava 2024-04-04T14:38:15+02:00 Read More Miguel Martínez-Cava 2024-04-04T14:38:15+02:00 April 4, 2024 | mAbxience and Teva Announce Strategic Global Licensing Agreement for Oncology Biosimilar Candidate Miguel Martínez-Cava 2024-04-04T14:38:15+02:00 Press releases | Miguel Martínez-Cava 2024-04-04T14:38:15+02:00 Read More Miguel Martínez-Cava 2024-02-26T08:56:52+01:00 February 26, 2024 | The Future of Biosimilars: Trends and Predictions Miguel Martínez-Cava 2024-02-26T08:56:52+01:00 Read More VIEW ALL Terms of use Privacy policy Cookies policy Code of conduct and compliance Copyright 2024 mAbxience, creating a strong value in biosimilars and CDMO platform | Powered by Scienseed Page...

mabxience.com Whois

Domain Name: MABXIENCE.COM Registry Domain ID: 1585688416_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.ascio.com Registrar URL: http://www.ascio.com Updated Date: 2024-02-18T08:09:23Z Creation Date: 2010-02-17T08:46:35Z Registry Expiry Date: 2025-02-17T08:46:35Z Registrar: Ascio Technologies, Inc. Danmark - Filial af Ascio technologies, Inc. USA Registrar IANA ID: 106 Registrar Abuse Contact Email: abuse@ascio.com Registrar Abuse Contact Phone: +1.4165350123 Domain Status: ok https://icann.org/epp#ok Name Server: DNS1.CHEMOGROUP.NET Name Server: DNS2.CHEMOGROUP.NET DNSSEC: unsigned >>> Last update of whois database: 2024-05-18T08:09:43Z <<<